Campus Alert: Find the latest UMMS campus news and resources at

Search Close Search
Search Close Search
Page Menu

Leadership in Support of a Cure for Diabetes

The UMass Diabetes Center of Excellence (DCOE) is privileged to be supported by a Visiting Advocacy Committee (VAC). Each member shares a passionate commitment for diabetes care, research and ultimately the cure. VAC members have demonstrated their effective leadership by reaching the top of their respective professions. They donate their time to help advance the DCOE mission, and lead by example through their generous philanthropy.

  • Michael Aspinwall

    Michael Aspinwall

    Co-Founder & CEO of Stability Health, whose mission is to improve health outcomes for individuals with diabetes. Mike's motivation stems from wanting to help people like his dad, who lived with T1D for 60 years. His father was the first person in Massachusetts to ever use an insulin pump.


  • Ronny Bachrach

    Ronny Bachrach

    Ronny lives with type 1 diabetes and is excited to engage with groups working to better the lives of those living with the disease. She's a member of the Center for Nutrition and Metabolism Advisory Committee at Beth Israel Deaconess Medical Center (BIDMC) and also serves on the Board of Overseers at BIDMC.

  • Michael Brockelman

    Michael Brockelman

    Michael was diagnosed with type 1 diabetes in 1974 at the age of 35. He is a partner and attorney at Bowditch & Dewey, where he’s worked for over 50 years.  Charitable work includes former: Trustee for the Barton Center for Diabetes Education; President of Greater Worcester Community Foundation; and Medical Center of Central Massachusetts Foundation Board of Trustees. 

  • John Cammett

    John Cammett

    John has type 1 diabetes and is inspired by his mother who has lived with T1D for over 56 years. He serves on the JDRF finance committee and lends his business expertise and financial support to new therapies and technologies. John is a lifelong entrepreneur with over 30 years of experience in all aspects of real estate, including finance, investment, management, and leasing for the transportation and logistics industry. 

  • Mark Fuller

    Mark Fuller

    Living with type 1 diabetes himself, Mark has been active in the diabetes education community for over 25 years. He's Chairman & Treasurer of the George F. & Sybil H. Fuller Foundation, which funds term chairs for two of the principal scientists within the UMass Diabetes Center of Excellence. Mark also Past Chairman and current Treasurer of the Barton Center for Diabetes Education.

  • Judy Hunt

    Judy Hunt

    Judy has advocated for a T1D cure for 37 years since her daughter was diagnosed at the age of 2. She serves on JDRF’s International Board of Chancellors, Canada Board of Directors, and nPOD Ambassadors. She was the first public Board member of the AADE and NCBDE, and served on the National Institute of Diabetes and Digestive and Kidney Disease Council, Texas Diabetes Council, and Pennsylvania Diabetes Academy. 

  • Nicole Johnson

    Nicole Johnson, PhD

    In 1999, Nicole became the first ever Miss America winner living with type 1 diabetes, and used the platform to publicize her use of an insulin pump. Today Nicole is a nationally recognized advocate for diabetes research and education, as well as National Director of JDRF Mission.  She's published several books related to diabetes.

  • Margery Perry

    Margery Perry

    Margery has been a diabetes advocate for more than 30 years, ever since her daughter was diagnosed with type 1 diabetes at age 7. She is Chair of the JDRF Research Committee, and has also been a member of NIH’s National Institute of Diabetes, Digestive and Kidney Diseases Advisory Council. Margery sits on several diabetes foundation boards, including Taking Control of Your Diabetes and Insulin for Life.

  • Charles Queenan

    Charles Queenan

    Charles has a daughter who was diagnosed with T1D at age 3.  He's a biotech entrepreneur, dedicated to research and innovation in the diabetes field for over 20 years. Charles is Founder and CEO of Forkhead BioTherapeutics, developing an oral therapy to treat insulin-dependent diabetes. He served as Chair of Research on the International Board of the JDRF, and was SVP New Ventures at JDRF.  

  • Joseph Vicidomino

    Joseph Vicidomino

    Joe’s grandson was diagnosed with type 1 diabetes at age 2. As a Global Vice Chair (Retired) with Ernst & Young, he has experience developing and leading the implementation of solutions to complex challenges faced by various types of organizations ranging in size from emerging businesses to large global companies. Joe is leveraging his experiences to advance the mission of the DCOE.